Silica-Immobilized NHC–CuI
ether (3 mLϫ2) was added, and the slurry was stirred, then filtered
using a sintered-glass funnel. The residue was washed with diethyl
ether to ensure removal of the product from the surface of the
catalyst. The combined organic phases were dried with Na2SO4,
filtered, concentrated, and the residue was purified by flash
chromatography on silica gel (eluant: hexane/ethyl acetate, 3:1,
N-[1-(1-Cyclohexyl-3-phenyl-2-propynyl)]piperidine:[34] 1H NMR
(300 MHz, CDCl3): δ = 7.44–7.40 (m, 2 H, ArH), 7.30–7.25 (m, 3
H, ArH), 3.12 (d, J = 9.9 Hz, 1 H, CϵCCH), 2.66–2.58 (m, 2 H,
NCH2), 2.44–2.34 (m, 2 H, NCH2), 2.14–1.98 (m, 2 H, CH2), 1.80–
1.70 (m, 2 H, CH2), 1.70–1.36 (m, 8 H, CH2), 1.34–0.89 (m, 5 H,
CH2) ppm. 13C NMR (75 MHz, CDCl3): δ = 131.9, 128.4, 127.7,
v/v) to give the corresponding A3-coupling product N-[1-(3-phen- 123.8, 87.9, 86.3, 64.7, 39.7, 31.4, 30.5, 27.0, 26.4, 26.1, 24.8 ppm.
ylprop-2-ynyl)]piperidine as a colorless oil (190 mg, 95% yield).
N-[4-(3-Phenyl-1-propyl-2-propynyl)]piperidine:[35]
(300 MHz, CDCl3): δ = 7.44–7.42 (m, 2 H, ArH), 7.28–7.26 (m, 3
H, ArH), 3.51–3.47 (m, 1 H, CϵCCH), 2.72–2.65 (m, 2 H, NCH2),
1H
NMR
N-[1-(3-Phenylprop-2-ynyl)]piperidine:[29] 1H NMR (300 MHz,
CDCl3): δ = 7.43–7.40 (m, 2 H, ArH), 7.27–7.24 (m, 3 H, ArH),
3.45 (s, 2 H, CϵCCH2), 2.54 (br. s, 2ϫ2 H, NCH2), 1.65–1.58 (m, 2.50–2.48 (m, 2 H, NCH2), 1.72–1.53 (m, 6 H, NCH2CH2), 1.46–
2ϫ2 H, NCH2CH2), 1.45–1.42 (m, 2 H, NCH2CH2CH2) ppm. 13
NMR (75 MHz, CDCl3): δ = 131.4, 127.9, 127.7, 123.1, 84.8, 84.7,
53.2, 48.2, 25.7, 23.7 ppm.
C
1.41 (m, 4 H, CH3CH2), 0.96 (t, J = 7.2 Hz, 3 H, CH3) ppm. 13C
NMR (75 MHz, CDCl3): δ = 131.7, 128.2, 127.8, 123.7, 88.2, 85.7,
58.3, 35.7,29.8, 26.9, 24.7, 20.2, 14.0 ppm.
N-[1-(3-Phenylprop-2-ynyl)]morpholine:[30] 1H NMR (300 MHz,
CDCl3): δ = 7.45–7.41 (m, 2 H, ArH), 7.29–7.27 (m, 3 H, ArH),
3.76–3.73 (t, J = 4.8 Hz, 2ϫ2 H, OCH2),3.48 (s, 2 H, CϵCCH2),
2.63–2.60 (t, J = 4.8 Hz, 2ϫ2 H, NCH2) ppm. 13C NMR (75 MHz,
CDCl3): δ = 131.6, 128.2, 128.1, 123.0, 85.5, 84.1, 66.8, 52.4,
48.0 ppm.
N-(1,3-Diphenyl-2-propynyl)piperidine:[36] 1H NMR (300 MHz,
CDCl3): δ = 7.65–7.63 (m, 2 H, ArH), 7.53–7.50 (m, 2 H, ArH),
7.38–7.28 (m, 6 H, ArH), 4.82 (s, 1 H, CϵCCH), 2.61–2.56 (m,
2ϫ2 H, NCH2), 1.63–1.56 (m, 4 H, NCH2CH2), 1.48–1.42 (m, 2
H, NCH2CH2CH2) ppm. 13C NMR (75 MHz, CDCl3): δ = 138.8,
132.0, 128.7, 128.4, 128.2, 127. 6, 123.6, 87.9, 86.3, 62.6, 59.8, 26.4,
24.7 ppm.
N,N-Dibenzyl-3-phenylprop-2-ynylamine:[31] 1H NMR (300 MHz,
CDCl3): δ = 7.49–7.46 (m, 2 H, ArH), 7.42–7.40 (m, 4 H, ArH),
7.31–7.17 (m, 9 H, ArH), 3.73 (s, 2ϫ2 H, PhCH2), 3.44 (s, 2 H,
CϵCCH2) ppm. 13C NMR (75 MHz, CDCl3): δ = 138.8, 131.7,
129.0, 128.2, 127.8, 127.0, 123.4, 85.8, 84.4, 57.7, 42.1 ppm.
N-[1-(4-Methylphenyl)-3-phenyl-2-propynyl]piperidine:[36] 1H NMR
(300 MHz, CDCl3): δ = 7.52–7.48 (m, 4 H, ArH), 7.32–7.27 (m, 3
H, ArH), 7.10 (d, J = 8.1 Hz, 2 H, ArH), 4.75 (s, 1 H, CϵCCH),
2.57–2.53 (m, 2ϫ2 H, NCH2), 2.33 (s, 3 H), 1.62–1.51 (m, 2ϫ2 H,
NCH2CH2), 1.45–1.40 (m, 2 H, NCH2CH2CH2) ppm. 13C NMR
(75 MHz, CDCl3): δ = 137.2, 135.8, 132.1, 129.0, 128.8, 128.5,
128.2, 123.7, 87.9, 86.7, 62.4, 51.0, 26.4, 24.8, 21.4 ppm.
N,N-Dicyclohexyl-3-phenylprop-2-ynylamine:[32]
1H
NMR
(300 MHz, CDCl3): δ = 7.39–7.37 (m, 2 H, ArH), 7.27–7.25 (m, 3
H, ArH), 3.69 (s, 2 H, CϵCCH2), 2.85–2.78 (m, 2ϫ1 H, NCH),
1.92–1.88 (m, 2ϫ2 H, NCHCH2), 1.80–1.76 (m, 2ϫ2 H,
N-[1-(4-Methoxyphenyl)-3-phenyl-2-propynyl]piperidine:[36]
1H
NCHCH2), 1.43–1.06 (m, 2ϫ6 H, NCHCH2CH2CH2CH2) ppm. NMR (300 MHz, CDCl3): δ = 7.55–7.48 (m, 4 H, ArH), 7.30–7.26
13C NMR (75 MHz, CDCl3): δ = 131.5, 128.2, 127.6, 124.0, 89.7, (m, 3 H, ArH), 6.90–6.85 (m, 2 H, ArH), 4.73 (s, 1 H, CϵCCH),
83.3, 57.6, 35.8, 31.4, 29.8, 27.0, 26.4 ppm.
3.74 (s, 3 H, OCH3), 2.56–2.53 (m, 2ϫ2 H, NCH2), 1.62–1.53 (m,
2ϫ2 H, NCH2CH2), 1.45–1.39 (m, 2 H, NCH2CH2CH2) ppm. 13
NMR (75 MHz, CDCl3): δ = 159.0, 131.8, 130.0, 129.1, 128.0,
C
N,N-Diisopropyl-3-phenylprop-2-ynylamine:[31]
1H
NMR
(300 MHz, CDCl3): δ = 7.41–7.38 (m, 2 H, ArH), 7.28–7.26 (m, 3
H, ArH), 3.66 (s, 2 H, CϵCCH2), 3.27 (sept, J = 7.2 Hz, 2ϫ1 H,
NCH), 1.16 (d, J = 6.6 Hz, 4ϫ3 H, CH3) ppm. 13C NMR
(75 MHz, CDCl3): δ = 131.2, 128.0, 127.4, 123.6, 88.9, 83.4, 48.6,
34.8, 20.6 ppm.
127.8, 123.1, 112.9, 87.9, 86.7, 61.8, 55.2, 50.4, 26.4, 24.5 ppm.
N-[1-(4-Chlorophenyl)-3-phenyl-2-propynyl]piperidine:[36] 1H NMR
(300 MHz, CDCl3): δ = 7.56 (d, J = 8.7 Hz, 2 H, ArH), 7.50–7.47
(m, 2 H, ArH), 7.32–7.27 (m, 5 H, ArH), 4.73 (s, 1 H, CϵCCH),
2.54–2.50 (m, 2ϫ2 H, NCH2), 1.59–1.53 (m, 2ϫ2 H, NCH2CH2),
1.43–1.39 (m, 2 H, NCH2CH2CH2) ppm. 13C NMR (75 MHz,
CDCl3): δ = 137.4, 133.4, 132.0, 130.1, 128.5, 128.3, 123.3, 88.4,
85.6, 62.0, 61.8, 50.8, 26.4, 24.5 ppm.
N-Cyclohexyl-3-phenylprop-2-ynylamine: 1H NMR (300 MHz,
CDCl3): δ = 7.44–7.41 (m, 2 H, ArH), 7.28–7.25 (m, 3 H, ArH),
3.46 (s, 2 H, CϵCCH2), 2.82–2.79 (m, 1 H, NCH), 2.56–2.52 (m,
2ϫ2 H, NCH2), 1.65–1.62 (m, 2ϫ2 H, NCH2CH2), 1.45–1.43 (m,
2 H, NCH2CH2CH2) ppm. 13C NMR (75 MHz, CDCl3): δ = 131.6,
128.1, 127.8, 123.2, 85.0, 84.9, 53.3, 48.4, 25.8, 23.8 ppm. C15H19N
(213.32): calcd. C 84.46, H 8.98, N 6.57; found C 84.28, H 9.05, N
6.67.
N-[1-(3-Chlorophenyl)-3-phenyl-2-propynyl]piperidine:[36] 1H NMR
(300 MHz, CDCl3): δ = 7.69–7.65 (m, 1 H, ArH), 7.61–7.55 (m, 3
H, ArH), 7.40–7.34 (m, 3 H, ArH), 7.32–7.29 (m, 2 H, ArH), 4.73
(s, 1 H, CϵCCH), 2.68–2.58 (m, 2ϫ2 H, NCH2), 1.72–1.59 (m,
2ϫ2 H, NCH2CH2), 1.57–1.48 (m, 2 H, NCH2CH2CH2) ppm. 13
C
N-(1,3-Diphenyl-2-propynyl)aniline:[9d] 1H NMR (300 MHz,
CDCl3): δ = 7.70–7.65 (m, 2 H, ArH), 7.45–7.20 (m, 10 H, ArH),
6.85–6.79 (m, 3 H, ArH), 5.50 (s, 1 H, CϵCCH), 4.32 (s, 1 H, NH)
ppm. 13C NMR (75 MHz, CDCl3): δ = 146.9, 139.9, 132.2, 129.5,
129.1, 128.6, 128.5, 128.2, 127.6, 123.1, 118.9, 114.5, 88.8, 85.4,
50.9 ppm.
NMR (75 MHz, CDCl3): δ = 140.9, 134.7, 132.1, 129.6, 128.7,
128.5, 128.2, 127.7, 126.3, 123.4, 88.6, 85.5, 62.1, 50.9, 26.4,
24.7 ppm.
N-[1-(2-Chlorophenyl)-3-phenyl-2-propynyl]piperidine:[37] 1H NMR
(300 MHz, CDCl3): δ = 7.84 (d, J = 7.5 Hz, 1 H, ArH), 7.59–7.56
(m, 2 H, ArH), 7.47–7.26 (m, 6 H, ArH), 5.19 (s, 1 H, CϵCCH),
2.71–2.68 (m, 2ϫ2 H, NCH2), 1.70–1.62 (m, 2ϫ2 H, NCH2CH2),
1.51–1.48 (m, 2 H, NCH2CH2CH2) ppm. 13C NMR (75 MHz,
CDCl3): δ = 136.5, 134.8, 131.9, 130.7, 129.9, 128.9, 128.4, 128.2,
126.3, 123.3, 87.8, 85.9, 59.4, 50.9, 26.3, 24.6 ppm.
N-[4-(1-Isopropyl-3-phenyl-2-propynyl)]piperidine:[33] 1H NMR
(300 MHz, CDCl3): δ = 7.44–7.40 (m, 2 H, ArH), 7.32–7.27 (m, 3
H, ArH), 2.99 (d, J = 9.9 Hz, 1 H, CϵCCH), 2.68–2.64 (m, 2 H,
NCH2), 2.44–2.40 (m,
CH3CHCH3), 1.64–1.43 (m, 6 H, NCH2CH2CH2CH2), 1.12 (d, J
6.6 Hz, H, CH3CHCH3), 1.03 (d, 6.6 Hz, H,
2 H, NCH2), 1.96–1.88 (m, 1 H,
=
3
J
=
3
N,N-Dibenzyl[3-(p-tolyl)prop-2-ynyl]amine:[29] 1H NMR (300 MHz,
CH3CHCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 131.9, 128.4, CDCl3): δ = 7.43–7.18 (m, 12 H, ArH), 7.10 (d, J = 7.8 Hz, 2 H,
127.8, 123.9, 87.9, 85.7, 65.7, 50.6, 30.6, 26.2, 24.7, 20.7, 19.9 ppm.
ArH), 3.72 (s, 2ϫ2 H, PhCH2), 3.46 (s, 2 H, CϵCCH2), 2.30 (s, 3
Eur. J. Org. Chem. 2008, 2255–2261
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2259